Extraction of spectral based measures from MEG background oscillations in Alzheimer's disease by Poza, J et al.
Extraction of spectral based measures from MEG background 
oscillations in Alzheimer’s disease 
 
Jesús Poza1, Roberto Hornero1, Daniel Abásolo1, Alberto Fernández2, María 
García1 
1
 Grupo de Ingeniería Biomédica, E.T.S. Ingenieros de Telecomunicación, University of 
Valladolid, Spain 
2
 Centro de Magnetoencefalografía Dr. Pérez-Modrego, Facultad de Medicina, University 
Complutense of Madrid, Spain 
 
 
AUTHOR’S ADDRESS:  Jesús Poza 
E.T.S. Ingenieros de Telecomunicación 
University of Valladolid 
Camino del Cementerio s/n 
47011 - Valladolid (Spain) 
Phone: +34 983 42300, ext. 5569 
Fax: +34 983 423667 
E-mail: jespoz@tel.uva.es 
 
 2 
Abstract 
 In this study, we explored the ability of several spectral based measures to summarize 
the information of the power spectral density (PSD) function from spontaneous 
magnetoencephalographic (MEG) activity in Alzheimer’s disease (AD). The MEGs of 20 AD 
patients and 21 elderly controls were recorded with eyes closed at rest during 5 min from 148 
channels. Five spectral parameters were estimated from PSD: mean frequency (MF), 
individual alpha frequency (IAF), transition frequency (TF), 95% spectral edge frequency 
(SEF95) and spectral entropy (SE). To reduce the dimensionality of the problem, we applied a 
principal component analysis. According to our results, MF was the best discriminating index 
between both groups (85.00% sensitivity, 85.71% specificity) indicating a shift to the left of 
the power spectrum in AD. A significant MEG slowing was also observed using both IAF (p 
< 0.001) and TF (p < 0.01). The lowest classification statistics (65% sensitivity, 76.19% 
specificity) were obtained with SEF95. However, these results were also significant (p < 
0.05). This fact points out that there is a variation in the spectral content at high frequencies of 
AD patients and controls. Finally, a significant decrease of irregularity in the AD group was 
observed with SE, with results close to those obtained with MF (90.00% sensitivity, 76.19% 
specificity). In conclusion, a complete description of PSD can help to increase our insight into 
brain dysfunction in AD and to extract spectral patterns specific to the disease. 
 
Keywords: Alzheimer’s disease; Magnetoencephalogram; Power Spectral Density; Principal 
Component Analysis. 
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1. Introduction 
 Alzheimer's disease (AD) is a progressive and irreversible brain disorder of the central 
nervous system, which represents the most common form of dementia in western countries 
[1]. AD is characterized by loss of mental and physical abilities severe enough to interfere 
with normal activities of daily living. 
 Usually, AD starts to destroy neurons (nerve cells) in parts of the brain that are 
responsible for storing and retrieving new information, including the temporal lobe and the 
hippocampus. Then, AD affects the areas responsible for language and reasoning in the 
cerebral cortex. Eventually, many other areas of the brain are affected by atrophy with the 
result that AD patients may wander, be unable to engage in conversation, appear 
uncooperative and non-responsive, become helpless and incontinent and, in extreme cases, 
need complete care. The autopsy of AD patients shows that the regions of the brain affected 
by the disease contain two abnormal structures: neurofibrillary tangles and beta-amyloid 
plaques. Neurofibrillary tangles are twisted fibers caused by changes in the tau protein. The 
beta-amyloid plaques are formed by insoluble filamentous deposits of beta-amyloid, found in 
the minute gaps between nerve cells. Although it is not exactly clear how these structures 
cause problems, many researchers believe that their formation blocks the normal transport of 
the electrical messages between the neurons and, finally, leads to neuronal death [2]. 
 Nowadays, there is no single test that can accurately predict who will develop AD. 
Physicians can make a probable diagnosis on living patients with a complete medical history, 
neurological and psychological tests, a physical exam, standard laboratory tests and a brain-
imaging scan. AD diagnosis can be made with up to 90% accuracy by experienced physicians, 
once symptoms begin [3,4]. In order to accomplish a diagnosis with 100% certainty, 
examination of brain tissue after death is needed [5]. 
 It is important to obtain an early and accurate diagnosis of AD, since it enables to 
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develop strategies for coping with the disease. Moreover, drug intervention works better in 
the earliest stages of the disease. In this sense, electrical activity in the brain has been widely 
analyzed to improve quality of diagnosis and to achieve early hallmarks of AD. Both 
electroencephalogram (EEG) and magnetoencephalogram (MEG) are generated by 
synchronous oscillations of pyramidal neurons. Nevertheless, they reflect slightly different 
characteristics, since EEG is sensitive to all primary currents and MEG is only affected by 
current flows oriented parallel to the scalp [6,7]. Other difference between EEG and MEG 
arises from the insensitivity of magnetic fields to inhomogeneities of the head. Electrical 
activity is more affected than magnetic oscillations by skull and extracerebral brain tissues. 
Moreover, EEG rhythms can be significantly influenced by some technical and 
methodological issues, like distance between electrodes, sensor placement or reference point. 
Thus, MEG can be seen as a complementary signal to EEG, which is less distorted by head 
structures, provides reference-free recordings and offers higher spatial resolution than 
conventional electroencephalography [7]. 
 In relation to the aforementioned electromagnetic recordings, both EEG and MEG 
background oscillations exhibit several abnormalities in AD (for recent reviews, we refer to 
[8] and [9]). Hence, in moderate and severe AD patients an increase of the power in the low 
frequency bands (i.e., delta and theta) and a decrease in the high frequency bands (i.e., alpha 
and beta) have been observed, both in EEG [10–13] and MEG studies [14,15]. Coherence 
values of the alpha and beta bands also decrease in AD patients when compared with controls 
using EEG [16,17]. This result is supported by some MEG studies, where a decreased 
coherence in the alpha band has been found [18]. However, a general decrease of coherence 
values in all frequency bands has been reported when analyzing MEG recordings [14]. On the 
other hand, nonlinear studies suggest that electromagnetic brain activity in AD is globally less 
complex and more regular than in elderly controls [19–25]. Nevertheless, some authors 
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indicate that the reduction in MEG complexity depends on the frequency band [26]. It should 
be pointed out that nonlinear properties of electromagnetic recordings are associated with 
their linear characteristics (e.g. the relative power spectrum) [8]. Hence, an increase in low 
frequency oscillations might produce a wrongly decreased dynamical complexity [9]. To 
avoid this incorrect interpretation, surrogate data testing can be employed. Briefly, the method 
constructs a surrogate time series with the same linear properties as the original one, but 
varying its nonlinear structure. Then, the nonlinear parameter is calculated for each time 
series and, finally, they are compared. In this way, Jelles et al. [27] used the surrogate data 
method with EEG recordings to compute the correlation dimension. They found no change in 
the nonlinear structure of the EEG in very mild AD patients and elderly controls. 
 Several studies have also analyzed the so called slowing of the spontaneous 
EEG/MEG activity using spectral based measures. They characterize the shape of the power 
spectrum. A power spectrum shifted to the left has been observed in AD patients’ EEG 
[28,29], along with an absence of a dominant activity from 6.5 to 12 Hz [30,31]. The 
topography of the EEG power spectrum in AD has also been studied by means of power 
measures [32] and using several spectral parameters like mean frequency [10,11,13,28,33,34], 
peak frequency [11,28,33,35] and transition frequency [35]. While the EEG has been broadly 
analyzed using spectral parameters, only a few studies have investigated the MEG spectral 
patterns in AD. Studies analyzing spontaneous MEG recordings have employed mean 
frequency [36] and peak frequency [14, 15]. Their results are in accordance with previous 
EEG studies reporting a decrease in characteristic frequencies in AD, which was accentuated 
by the severity of the disease. 
 The aforementioned studies analyzed raw signals (i.e. the recorded MEG brain 
activity). However, some attempts have been made to reconstruct the sources which generate 
these recordings. Thus, works counting sources have also found differences between AD 
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patients and controls [15,37]. Osipova et al. [15] proposed that MEG slowing might be due to 
an increase in activation of low frequency oscillators rather than slowing of existing sources. 
In this sense, Fernández et al. [37] observed an enhanced value in dipole density in the delta 
and theta bands of MEG background activity in AD. This result could be related to the 
increase of slow rhythms in AD. Source reconstruction studies are closely related to those 
analyzing MEG recordings. Nevertheless, it should be noticed that they studied different 
characteristics of the oscillatory brain activity. Reconstructed sources reflect the internal 
generators of MEG activity, whereas raw signals represent the oscillatory activity generated 
by these sources. Hence, they can be viewed as complementary analyses which can help to 
understand the brain dynamics in AD. 
 From another point of view, power spectral density (PSD) has also been used to 
extract markers of correlation with anaesthetic drug effect. Thus, an estimation of the spectral 
content of PSD, called 95% spectral edge frequency, has been studied to monitor depth of 
anaesthesia [38,39]. Similarly, parameters from the context of nonlinear dynamics have also 
been employed to yield additional information to linear spectral based measures. One of them 
is the spectral entropy, which represents the Shannon entropy computed over the normalized 
power spectral density function [38–40]. 
 In this study, we analyzed spontaneous MEG recordings from AD patients and healthy 
controls to identify discriminating features between both groups. Hence, we calculated five 
spectral parameters (mean frequency, individual alpha frequency, transition frequency, 95% 
spectral edge frequency and spectral entropy), which could help to summarize the power 
spectrum. While a few MEG studies have analyzed individually some of these indexes as AD 
markers (i.e., mean frequency and individual alpha frequency), we calculated simultaneously 
the aforementioned five spectral parameters. Therefore, we achieved a complete description 
of the PSD function. 
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2. Materials 
2.1. Selection of subjects 
 Twenty patients (7 men and 13 women, age = 73.05 ± 8.65 years, mean ± standard 
deviation SD), recruited from the Asociación de Familiares de Enfermos de Alzheimer 
(AFAL), participated in the study. To obtain the clinical diagnosis, exhaustive medical, 
physical, neurological, psychiatric and neuropsychological examinations were performed. 
Tests were complemented with brain scans to exclude other causes of dementia and with 
Mini-Mental State Examination (MMSE) to evaluate the degree of dementia [41]. The mean 
MMSE score for the patients was 17.85 ± 3.91 (mean ± SD). All patients fulfilled the criteria 
of probable AD according to the clinical guidelines of the National Institute of 
Communicative Disorders and Stroke and the AD and Related Disorders Association 
(NINCDS-ADRDA) [42]. In addition, AD patients did not suffer from other medical, 
neurological and psychiatric diseases, and were not taking any medication that could 
significantly affect MEG recordings (cholinesterase inhibitors, benzodiazepines or 
antidepressives). 
 Twenty-one healthy elderly subjects (9 men and 12 women, age = 70.29 ± 7.07 years, 
mean ± SD) formed the control group. They were volunteers with no history of neurological 
or psychiatric disorders. The mean MMSE score was 29.10 ± 1.00 points. It should be noted 
that their mean age was not significantly different from the mean age of AD patients (p > 
0.05). 
 All control subjects and all caregivers of the demented patients gave their consent to 
participate in the study, which was approved by the local ethics committee. 
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2.2. MEG data collection 
 Data recording was performed using a 148-channel whole-head magnetometer 
(MAGNES 2500 WH, 4D Neuroimaging). The register device was located in a magnetically 
shielded room in the Centro de Magnetoencefalografía Dr. Pérez-Modrego, Spain. In order to 
avoid segments contaminated with artefacts, MEG recordings were obtained with subjects in 
a relaxed state, awake and with eyes closed. In order to avoid and control drowsiness effects, 
subjects’ behaviour and level of consciousness were controlled during the whole recording by 
means of a video-camera. Hence, five minutes of MEG background activity were recorded at 
a sampling rate of 678.17 Hz. Data were filtered using both a 0.1-200 Hz hardware bandpass 
filter and a 50 Hz notch filter. To reduce data length, the recordings were downsampled by a 
factor of four, obtaining a sampling rate of 169.54 Hz. 
 The recordings were contaminated by both low and high-frequency artefacts. 
Whereas, low-frequency artefacts were typically due to eye movements, high-frequency 
artefacts were usually generated by muscle activity. An experienced physician, who was blind 
to the patients’ diagnosis, selected artefact-free time segments by visual inspection. Signals 
were arranged in consecutive 10-s artefact free epochs, obtaining a mean of 26.4 ± 5.5 
fragments (mean± SD) per subject and per channel. Finally, each segment of 1696 samples 
was processed with a 0.4-70 Hz digital bandpass filter. 
 
3. Methods 
3.1. Spectral analysis and definition of parameters 
 To characterize the spectral content of each MEG recording, we used the Fourier 
transform and calculated five parameters. Initially, we computed the power spectral density 
(PSD) for each MEG epoch, which was estimated from the Fourier transform of the 
autocorrelation function. Then, we obtained the mean PSD per channel and subject from 1 Hz 
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to 64 Hz. 
 The first estimated index was the mean frequency (MF), which offers a simple means 
of summarizing the whole spectral content of PSD. It is defined as the frequency which 
comprises 50% of the power. This issue is represented in the equation 1, where MF is 
numerically calculated from the discrete PSD between 1 Hz to 64 Hz. It should be noticed 
that the discrete PSD was computed as the Fourier transform of the biased estimate of the 
autocorrelation function. Thus, if the raw signal contains N samples, then the autocorrelation 
function is a vector of length 2N-1. Due to this fact, the spectral resolution was 0.05 Hz in the 
present study. 
 
( ) ( )∑∑ =⋅
MF
Hz
Hz
Hz
fPSDfPSD
1
64
1
5.0  (1) 
 
 Then, we computed the individual alpha frequency (IAF), also named peak frequency. 
Alpha oscillations are dominant in the EEG of resting normal subjects, with the exception of 
irregular activity in the delta band and lower frequencies [43]. This issue involves that the 
PSD displays a peak around the alpha band (8-13 Hz). To detect the IAF, we calculated the 
mean frequency in the extended alpha band (4-15 Hz), since we observed several peaks in this 
range [35]. This is shown in the next equation. 
 
( ) ( )∑∑ =⋅
IAF
Hz
Hz
Hz
fPSDfPSD
4
15
4
5.0  (2) 
 
 Previous EEG studies estimated the so called transition frequency (TF), as the 
minimum power in the theta band [35]. This index is strongly associated to the IAF. In this 
work, we computed the TF as the mean frequency from 1 Hz to the IAF as it is shown in 
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equation 3. Hence, we obtained an estimation of the minimum in the delta and theta range that 
is not affected by local minima and takes into account the contribution of the delta band. 
 
( ) ( )∑∑ =⋅
TF
Hz
IAF
Hz
fPSDfPSD
11
5.0  (3) 
 
 Similar to the MF, the 95% spectral edge frequency (SEF95) is estimated as the 
frequency which comprises 95% of the power. Although it was also possible to calculate the 
90% spectral edge frequency (SEF90), some authors have indicated that SEF95 is more stable 
and reliable than SEF90 [44]. Thus, we used SEF95 as an indicator of the upper limit in the 
spectral content of PSD. Equation 4 represents the expression from which the SEF95 is 
calculated analogously to the previous parameters. 
 
( ) ( )∑∑ =⋅
95
1
64
1
95.0
SEF
Hz
Hz
Hz
fPSDfPSD  (4) 
 
 Finally, the spectral entropy (SE) was estimated to measure the flatness of PSD. It 
represents a disorder measure, which can be used as an estimation of MEG irregularity [45]. 
Thus, a uniform spectrum with a broad spectral content (e.g. white noise) yields a high SE 
value, whereas a more predictable signal that contains only a few spectral components (e.g. a 
sum of sinusoids) gives a low SE value [46]. To calculate SE, we applied the definition of 
Shannon’s entropy computed over the normalized PSD function [45]. This is stated in 
equation 5, where PSDn(f) denotes the normalized PSD from 1 Hz to 64 Hz. 
 
( ) ( )[ ]∑
=
⋅−=
Hz
Hzf
nn fPSDfPSDSE
64
1
log  (5) 
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 All features were log-transformed to minimize problems with skewness and kurtosis 
[47]. Thus, we obtained parameters with a distribution closer to a normal curve. 
 
3.2. Principal Component Analysis (PCA) 
 After the estimation of the parameters, we had 148 values per subject, since MEG 
recordings proceeded from 148 channels. Due to the high spatial density of sensors, it is 
possible to hypothesize that there exists some redundancy. Therefore, the use of principal 
component analysis (PCA) could help to summarize information and detect correlations 
among our variables. 
 In order to detect redundancy, PCA identifies orthogonal directions of maximum 
variance in the original data. Then, they are projected into a lower-dimensionality space 
formed by a subset of the highest variance components. The new uncorrelated variables are 
called principal components and are ordered by decreasing variance. Hence, the first principal 
component accounts for as much of the variability in the data as possible, and each successive 
component explains as much of the remaining variability as possible. To determine the 
principal components that should be retained for further analysis, we can choose among 
several methods. We can use the broken stick model, Velicer’s partial correlation procedure, 
cross-validation, Bartlett’s test for equality of eigenvalues, Kaiser’s criterion, Cattell’s scree 
test and cumulative percentage of explained variance, among others [48,49]. Nevertheless, the 
selection of a complex criterion does not involve a significant improvement in most cases, as 
some authors have indicated [50]. Thereby, a simple selection rule can work just as well as an 
elaborated scheme.  
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3.3. Statistical analysis 
 We studied the differences between groups by means of Student’s t-test. Normality of 
distribution was assessed with Lilliefors test, whereas homoscedasticity was analyzed with 
Levene’s test. 
 We used notched boxplots to visualize the distribution of each parameter. This is a 
graph for descriptive statistics, which divides the ordered values of the data into four ‘equal’ 
parts, separated by three horizontal lines. The sample median is displayed as a line 
approximately in the middle of the box. Deviation of the distribution from symmetry is 
indicated by a shift of the median from the middle of the box. The 25th and 75th percentiles 
of the sample are established as the lower and upper lines of the box, respectively. The 
notches included in the box represent a graphic confidence interval about the median of a 
sample. In addition, boxplots show two lines extending above and below the box, which are 
called ‘whiskers’. They are drawn from each end of the box to the farthest observation outside 
the box extended to a maximum of 1.5 times the interquartile range. Any values beyond these 
whiskers are defined as data outliers and marked by the symbol, ‘+’ [51]. 
 Receiver Operating Characteristics (ROC) plots help us to assess the ability of the 
parameters to distinguish between groups [52]. ROC plots are graphs of sensitivity against 1-
specificity. The sensitivity represents the percentage of patients correctly classified and 
specificity is the proportion of controls properly identified. We also calculated the point 
closest to the left top corner of the graph (i.e. 100% sensitivity and 100% specificity) and 
marked it with the symbol ‘♦’. It indicates the optimum threshold that maximizes the 
accuracy, which is defined as the total number of patients and controls correctly recognized. 
Finally, we also employed the area under ROC curve (AUC) as a complementary measure of 
parameters’ performance to discriminate between both groups. 
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4. Results 
 Initially, we calculated the PSD for each 10 s epoch in the 148 channels. A mean PSD 
for each channel and each subject was obtained averaging the PSD functions of the different 
epochs. Figure 1 depicts the average relative power spectra for both groups. As it can be seen, 
the spectrum of AD patients is shifted to the left in comparison with controls. This fact 
supports the notion of EEG/MEG slowing in AD. The spectral parameters defined in the 
previous section were then computed from the aforementioned PSD functions. Table 1 
displays their mean values averaged for each group and for all channels, whereas figure 2 
depicts the notched boxplots with their distributions. AD patients showed frequencies (i.e., 
MF, IAF, TF and SEF95) significantly lower than control subjects, which points out the 
slowing of spontaneous MEG brain activity. In the case of spectral entropy, AD patients also 
obtained significantly lower mean values than healthy controls. This fact indicates that MEG 
background rhythms are less irregular in AD patients than in control subjects’ MEGs. In this 
sense, figure 1 shows a broader spectral content for control subjects than for AD patients. 
According to the definition of SE, AD patients’ MEG is a more predictable signal than 
magnetic brain oscillations of control subjects. 
------------------------------------------------------------ 
Insert Table 1 and Figures 1 and 2 around here 
------------------------------------------------------------ 
 Afterwards, parameters were log-transformed and PCA was applied. The percentage 
of variance, together with the accumulated percentage of variance explained by the first 5 
principal components are shown in table 2. It should be noted that the first principal 
component retained between 75.46% of variance in the TF parameter and 81.48% in the MF 
parameter. On the other hand, it should also be pointed out that the accumulated percentage of 
variance explained by the 5 first principal components reaches 91% for all parameters. These 
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values indicate that there exists a great amount of redundancy in the data of the 148 channels. 
In this way, PCA can help to reduce the dimensionality of the problem with a minimum loss 
of information. We retained only the first principal component for every parameter, since it 
explained more than 75% of the variance for all of them. Thus, the analysis scheme is 
simplified, at the same time that the interpretation of the results is easier than taking the 148 
values per subject simultaneously. 
------------------------------------------------------------ 
Insert Table 2 around here 
------------------------------------------------------------ 
 We analyzed the differences between the transformed features and calculated four 
statistics from the ROC plots (i.e., sensitivity, specificity, accuracy and AUC). Results are 
shown in table 3, while ROC plots are displayed in figure 3. It should be noticed that points 
marked in ROC plots represent sensitivity against 1–specificity for each threshold. The 
symbol ‘♦’ identifies the points with the maximum accuracy, which appear in table 3. The 
lowest p-value and the highest AUC were obtained with MF, a result that suggests MF 
showed the best global performance (AUC = 0.912, sensitivity = 85.00%, specificity = 
85.71% and accuracy = 85.37%). The p-value and AUC for SE were slightly lower than in 
MF (AUC = 0.888, sensitivity = 90.00%, specificity = 76.19% and accuracy = 82.93%). It 
should be noted that both MF and SE use the information of the broad spectrum in its 
definition. With regard to IAF and TF, the statistical differences were not as significant as 
those reached using MF. In this sense, we achieved a lower p-value, together with a higher 
AUC (AUC = 0.821, sensitivity = 80.00%, specificity = 80.95% and accuracy = 80.49%), 
with IAF than with TF (AUC = 0.760, sensitivity = 70.00%, specificity = 76.19% and 
accuracy = 73.17%). The lowest classification parameters (AUC = 0.698, sensitivity = 
65.00%, specificity = 66.67% and accuracy = 65.85%) were obtained with SEF95. 
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------------------------------------------------------------ 
Insert Table 3 and Figure 3 around here 
------------------------------------------------------------ 
 Finally, a stepwise discriminant analysis was performed to assess the combination of 
parameters which reached the best classification performance. Table 4 shows the variable 
groups that obtain an overall accuracy greater than the individual parameters. It should be 
noted that combinations of two parameters do not improve the accuracy of MF, but three or 
four spectral measures are needed. In a similar sense, the group of the five spectral indexes 
only reaches 85.37% of accuracy. With regard to the parameters selected in the stepwise 
discriminant analysis, both TF and SEF95 appear in almost all the combinations. Although 
these measures do not provide the best individual classification statistics, results point out that 
they contribute to improve the classification rates. 
------------------------------------------------------------ 
Insert Table 4 around here 
------------------------------------------------------------ 
 
5. Discussion 
 In this study, we compared the ability of several spectral based measures to distinguish 
between MEG background activity from 20 AD patients and 21 healthy controls. By using the 
PSD function, we estimated five spectral parameters (MF, IAF, TF, SEF95 and SE). Prior to 
statistical analysis, we reduced the dimensionality of the problem by using PCA, since MEG 
signals were recorded from 148 channels simultaneously. We selected the first principal 
component for each spectral parameter, as it explained more than 75% of the variance. 
Finally, the performance of each spectral index was assessed using several Student’s t-tests 
and ROC curves. The best results - the most significant differences and the highest global 
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classification statistics - were obtained with MF. SE also showed significant differences with 
an AUC close to that obtained with MF. On the other hand, the differences between both 
groups using IAF and TF were less significant as compared to MF. Nevertheless, IAF showed 
a lower p-value and higher AUC than TF. Finally, the highest p-value, along with the lowest 
AUC, was obtained with SEF95. When we combined the parameters to augment the 
classification rate, we found that only variable groups of three or four indexes provided 
accuracies greater than MF. Moreover, both TF and SEF95 played an important role to 
improve classification statistics, as they appeared in almost all the optimal combinations. 
 Further inspection of results points out that MF in AD patients’ MEGs is significantly 
lower than in healthy controls’ MEGs. Hence, averaged MF values for each group are, MFAD 
= 6.63 ± 3.01 Hz and MFC = 12.17 ± 3.87 Hz (henceforth all values are expressed as mean ± 
SD). These findings are in agreement with previous studies, which also analyzed spontaneous 
MEG signals in AD. Fernández et al. [36] reported a significant decrease in the mean 
frequency of AD patients and controls. As previously mentioned, MF of EEG background 
activity also decreases significantly in AD when compared with healthy controls 
[10,11,13,28,33,34]. With regard to the obtained mean values, they were strongly influenced 
by the frequency band used in the MF estimation, which was usually lower than in our study. 
Moreover, although EEG and MEG are related, they do not reflect identical information [7]. 
 Significant MEG slowing can also be observed when analyzing the IAF. We obtained 
averaged IAF values, IAFAD = 7.97 ± 1.15 Hz and IAFC = 9.40 ± 0.69 Hz. The mean values 
are in accordance with those obtained in other studies using MEG signals at rest. In this way, 
Osipova et al. [15] analyzed the brain activity in 11 AD patients and 12 elderly controls, 
reporting the mean values, IAFAD = 8.50 ± 1.36 Hz and IAFC = 9.50 ± 1.25 Hz. Their results 
did not show significant differences (p > 0.05), and the IAF in AD patients was slightly higher 
than in our study. A possible explanation for this fact may be that they analyzed MEG signals 
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from patients with a mean MMSE score of 20.8 ± 4.0. This value is slightly higher than our 
mean MMSE, indicating a less severe degree of dementia. In addition, they estimated the alpha 
peak as the maximum frequency in the alpha range, whereas we computed the IAF as the 
mean frequency from 4 Hz to 15 Hz to avoid the detection of local maxima [43]. Berendse et 
al. [14] also calculated the IAF of spontaneous MEG activity as the maximum in the extended 
alpha range. Nevertheless, the mean values they obtained were, IAFAD = 7.50 Hz and IAFC = 
10.80 Hz. Their results are different to our mean values and those obtained by Osipova et al. 
[15]. This can be due to the fact that Berendse et al. [14] only analyzed MEG signals from 5 AD 
patients and 5 controls, which represents a considerably small population. Regarding to the 
severity of AD subjects, they enrolled patients with a mean MMSE score of 19.8. The IAF 
has also been calculated in previous EEG studies analyzing brain activity at rest 
[11,28,31,33,35]. The obtained results showed a reduction in the frequency of the alpha peak, 
when it was calculated as the maximum in the alpha band [11,31,35], as well as the mean 
frequency in the alpha range [28,33]. 
 TF is closely related to IAF, since it is used in its definition. Our findings also indicate 
a significant slowing of the TF in AD, TFAD = 3.70 ± 1.40 Hz and TFC = 4.88 ± 1.23 Hz. This 
fact is in disagreement with the results obtained in a study analyzing EEG background activity 
of AD patients and elderly subjects, where no significant reduction in TF was reported [35]. 
Moretti et al. [35] obtained mean values of TF for each group, TFAD = 5.30 ± 1.07 Hz and TFC 
= 5.40 ± 0.80 Hz. It can be observed that TF for controls is similar to our findings, but for AD 
patients the values clearly differ. This might be due to the fact that AD patients were less 
severely demented, according to their mean MMSE score (20.58 ± 0.28). Moreover, the way to 
calculate the TF differs from the estimation of TF that we employed. As previously mentioned, 
we computed TF as the mean frequency from 1 Hz to IAF in order to avoid local minima and 
to take into account the contribution of the delta band. It should also be noticed that in this 
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case comparisons between both studies should be made with care, since we used MEG 
recordings while Moretti et al. [35] employed EEG signals. 
 Although SEF95 has been successfully employed to monitor depth of anaesthesia [38–
40], our results are less significant than those obtained with MF, IAF, TF and SE. This finding 
seems to indicate that there is little change in the spectral content at high frequencies when 
comparing AD patients and control subjects. Nevertheless, it should be noted that AD patients 
showed lower mean values than controls with SEF95, SEF95AD =31.05 ± 8.73 Hz and SEF95C 
= 37.03 ± 6.95 Hz. This fact supports the notion of slowing in the MEG spectrum of AD 
patients in comparison to elderly subjects, which was observed with the previous parameters. 
 The SE yielded significant differences, similar to those obtained using the MF. The 
AD patients’ mean SE values (0.83 ± 0.07) were lower than in controls (0.89 ± 0.03). 
According to the definition of SE, these results suggest that AD patients have a less irregular 
spectral distribution than healthy subjects [45]. This result should be interpreted in terms of 
the flatness of the frequency spectrum, i.e. AD patients have a less uniform spectral content 
than controls, as it is shown in figure 1. Previous studies analyzing MEG recordings at rest 
found a global loss of complexity in AD by using the Lempel-Ziv complexity, which 
represents the chance of new pattern generation in a discrete sequence [25]. Nevertheless, the 
loss of complexity was only observed in the high frequencies (14 Hz to 40 Hz), when 
individual frequency bands were analyzed [26]. In this case, van Cappellen van Walsum et al. 
[26] used the neural complexity to capture regularities based on the deviation from 
independence among subsets of a system. Abásolo et al. [22,24] reported a reduction of 
irregularity in AD patients’ EEG using SE, approximate entropy [22] and sample entropy 
[24]. Their results with SE were not significant (p > 0.05). On the other hand, significant 
differences were observed with both sample entropy and approximate entropy (p < 0.01). It 
should be noted that both approximate entropy (ApEn) and sample entropy (SampEn) are 
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embedding entropies. While ApEn computes the logarithmic likelihood that runs of patterns 
that are close (within r) for m contiguous observations remain close (within the same 
tolerance width r) on subsequent incremental comparisons, SampEn measures the self-
similarity in the time series and reduces the bias that introduces ApEn [24]. Decreased 
complexity in EEG background activity has also been observed analyzing several nonlinear 
measures as the Lempel-Ziv complexity [23], the first Lyapunov exponent [19] and the 
correlation dimension [19,20]. The first Lyapunov exponent is a measure of flexibility of 
information processing of the brain, whereas the correlation dimension reflects the number of 
independent variables that are necessary to describe the dynamics of the system [8]. Finally, it 
should be noted that these nonlinear measures may be wrongly influenced by the slowing of 
the power spectrum [9]. To avoid an incorrect interpretation of the parameters, a few EEG 
studies have employed surrogate data testing, exploring the nonlinearity of the EEG in AD. 
Thus, Jelles et al. [27] observed a more complex behaviour of AD patients when compared 
with controls, in terms of the correlation dimension. However, further works are needed to 
obtain more general conclusions. 
 Frequency parameters have shown a slowing of spontaneous MEG activity in AD. In 
this sense, some authors point out that the cholinergic system modulates the spontaneous 
cortical activity at the theta and alpha bands, along with the functional coupling in the theta 
band [53]. Given that cholinergic deficit involves a loss of the neurotransmitter aceltylcholine, 
this fact can be partly responsible of MEG slowing in AD. Nevertheless, AD is a 
heterogeneous disease, and therefore, it may not be sufficient to explain the different 
alterations of the magnetic brain activity. 
 It should be noted that the origin of the observed MEG slowing could be drug-related. 
We discarded this issue because to none of the patients were taking any medication which 
could affect electromagnetic brain activity at the moment of the recording. In a similar sense, 
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both EEG and MEG slowing have also been reported in other neurodegenerative diseases like 
mild cognitive impairment [13,36], vascular dementia [28,35,54], Lewy body dementia 
[18,31], major depression [34,55,56], dementia associated with Parkinson’s disease 
[31,57,58], Pick’s disease [59], Huntington’s chorea [60] and progressive supranuclear palsy 
[31]. To extract accurate markers of AD, further studies should analyze differences in the 
slowing of EEG/MEG rhythms when comparing AD and the aforementioned diseases. 
 Other limitation to comment is related with the small sample size that we employed, 
which determines the power of the statistical test. A small sample size increases beta (i.e., the 
probability of generating a false negative, or a type II error), while at the same time the power 
of the test decreases (i.e., 1-beta). Given that we fixed alpha to 0.05 (i.e., the probability of 
making a false positive, or a type I error), the only way to minimize beta is to increase the 
sample size. 
 Finally, it should be mentioned that by using PCA analysis we selected only one 
principal component for each parameter. This involves a loss of spatial information, which 
could be partially avoided by computing average spectra for a number of brain regions. Then, 
a repeated measures ANOVA with ‘Group’ and ‘Region’ as factors, could be performed to 
analyze the statistical significance. Nevertheless, when we use this approach we should take 
into account that a recording channel does not necessarily measure only the brain oscillations 
under that sensor, but it can reflect activity from other regions. Hence, to avoid an incorrect 
interpretation of results in terms of spatial patterns, we should perform some kind of source 
analysis. 
 
6. Conclusions 
 As previously mentioned, only a few MEG studies have explored the ability of 
spectral indexes as AD descriptors. Both MF and IAF have been analyzed individually in 
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previous works [14,15,36]. Nevertheless, to obtain a reliable description of the power 
spectrum, it might be more convenient to employ a set of measures, instead of summarizing 
the whole content of PSD using a single index. In this sense, to the best of our knowledge, 
this study may be considered the first attempt to characterize the power spectrum of 
spontaneous MEG activity in AD patients and healthy controls using all the aforementioned 
spectral parameters simultaneously. Our results support the notions that AD involves both a 
slowing and an irregularity reduction of electromagnetic brain activity when compared with 
elderly subjects. 
 It should also be noted that future efforts will be directed to increase the sample size, 
as well as to extend the results to other neurodegenerative diseases. In a similar way, further 
works will be addressed to obtain a minimal loss of spatial information by performing source 
analysis and using other dimensionality reduction techniques. 
 Summarizing, our findings suggest that a complete spectral description of the 
spontaneous MEG activity may help to obtain useful markers of AD contributing, at the same 
time, to the understanding of the disease. 
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Figures 
Figure 1. Mean relative power spectra of AD patients (AD) and healthy controls (C). 
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Figure 2. Notched boxplots displaying the distribution of each parameter for both groups and the 
corresponding p-values. (a) Mean frequency (MF). (b) Individual alpha frequency (IAF). (c) 
Transition frequency (TF). (d) 95% spectral edge frequency (SEF95). (e) Spectral entropy (SE). 
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Figure 3. ROC curves for each parameter. (a) Mean frequency. (b) Individual alpha frequency. 
(c) Transition frequency. (d) 95% spectral edge frequency. (e) Spectral entropy. The ROC curve 
values are marked with a dot, whereas the optimum threshold is indicated with the symbol ‘♦’. 
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Tables 
Table 1. Averaged values for all spectral parameters. 
 
 MF (Hz) IAF (Hz) TF (Hz) SEF95 (Hz) SE 
 Mean ± SD Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
AD patients 6.63 ± 3.01 7.97 ± 1.15 3.70 ± 1.40 31.05 ± 8.73 0.83 ± 0.07 
Controls 12.17 ± 3.87 9.40 ± 0.69 4.88 ± 1.23 37.03 ± 6.95 0.89 ± 0.03 
 
 
 
Table 2. Percentage of variance (% Var.), together with the accumulated percentage of 
variance (% Acc.) explained by the first 5 principal components for all parameters: mean 
frequency (MF), individual alpha frequency (IAF), transition frequency (TF), 95% spectral 
edge frequency (SEF95) and spectral entropy (SE). 
 
Parameters 
Principal components 
1st 2nd 3rd 4th 5th 
% Var. % Acc. % Var. % Acc. % Var. % Acc. % Var. % Acc. % Var. % Acc. 
MF 77.77 77.77 6.07 83.84 5.09 88.93 2.58 91.51 1.52 93.03 
IAF 81.48 81.48 7.01 88.48 3.52 92.00 1.86 93.86 1.29 95.15 
TF 75.46 75.46 8.00 83.46 5.54 89.01 2.75 91.76 1.63 93.39 
SEF95 76.71 76.71 7.35 84.06 3.64 87.70 3.15 90.85 2.19 93.04 
SE 75.62 75.62 7.09 82.71 3.62 86.33 3.03 89.35 2.19 91.54 
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Table 3. Sensitivity, specificity, accuracy, area under ROC curve (AUC) and p-values 
obtained with the first principal component for each parameter: mean frequency (MF), 
individual alpha frequency (IAF), transition frequency (TF), 95% spectral edge frequency 
(SEF95) and spectral entropy (SE). 
 
Parameters Sensitivity (%) Specificity (%) Accuracy (%) AUC p-value 
MF 85.00 85.71 85.37 0.912    < 0.00001 
IAF 80.00 80.95 80.49 0.821    < 0.00005 
TF 70.00 76.19 73.17 0.760       0.00190 
SEF95 65.00 66.67 65.85 0.698       0.01760 
SE 90.00 76.19 82.93 0.888       0.00023 
 
 
 
Table 4. Classification results of the stepwise discriminant analyses. 
Parameter combinations Sensitivity (%) Specificity (%) Accuracy (%) 
   MF, SEF95, TF      16/20 (80.00)      20/21 (95.24)      36/41 (87.80) 
   TF, SEF95, SE      15/20 (75.00)      21/21 (100.00)      36/41 (87.80) 
   IAF, SEF95, SE      15/20 (75.00)      21/21 (100.00)      36/41 (87.80) 
   MF, IAF, SEF95, TF      16/20 (80.00)      20/21 (95.24)      36/41 (87.80) 
   MF, IAF, SEF95, SE      15/20 (75.00)      21/21 (100.00)      36/41 (87.80) 
   IAF, SEF95, TF, SE      15/20 (75.00)      21/21 (100.00)      36/41 (87.80) 
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